Drug Shortage Report for BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Report ID | 204665 |
Drug Identification Number | 02512424 |
Brand name | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP |
Common or Proper name | Bupivacaine Hydrochloride In Dextrose Injection USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
Strength(s) | 7.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRASPINAL |
Packaging size | 10 x 2 mL vial / fiole |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-09-25 |
Actual start date | 2023-09-20 |
Estimated end date | 2023-11-17 |
Actual end date | 2023-11-10 |
Shortage status | Resolved |
Updated date | 2023-11-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-11-11 | English | Compare |
v11 | 2023-11-10 | French | Compare |
v10 | 2023-11-10 | English | Compare |
v9 | 2023-11-10 | French | Compare |
v8 | 2023-11-10 | English | Compare |
v7 | 2023-10-31 | French | Compare |
v6 | 2023-10-31 | English | Compare |
v5 | 2023-09-21 | English | Compare |
v4 | 2023-09-20 | French | Compare |
v3 | 2023-09-20 | English | Compare |
v2 | 2023-09-18 | French | Compare |
v1 | 2023-09-18 | English | Compare |
Showing 1 to 12 of 12